Literature DB >> 324671

Synergy, additivism and antagonism in immunosuppression. A critical review.

M C Berenbaum.   

Abstract

Mesh：

Substances：

Year:  1977        PMID： 324671      PMCID： PMC1540873     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN： 0009-9104            Impact factor:   4.330


× No keyword cloud information.
  33 in total

1.  THE RELATION OF RADIATION DOSAGE TO ENHANCEMENT, DEPRESSION, AND RECOVERY OF THE INITIAL FORSSMAN HEMOLYSIN RESPONSE IN RABBITS.

Authors:  W H TALIAFERRO; L G TALIAFERRO
Journal:  J Infect Dis       Date:  1964-10       Impact factor: 5.226

2.  AZASERINE AND THIOPURINES. I. INHIBITION OF S-180 MOUSE TUMOR AND ANTIBODY SYNTHESIS.

Authors:  H J HANSEN; J P VANDEVOORDE; K J BENNETT; W G GILES; S B NADLER
Journal:  J Lab Clin Med       Date:  1964-05

3.  INDUCTION OF TOLERANCE WITH DISRUPTED ANTIGEN, IMURAN, AND SUBLETHAL IRRADIATION.

Authors:  M F MCKNEALLY; W D KELLY; J RESNICK; C MARTINEZ
Journal:  Surg Forum       Date:  1964

4.  ENHANCED SUPPRESSION OF THE SECONDARY IMMUNE RESPONSE BY COMBINATION OF 6-MERCAPTOPURINE DUAZOMYCIN A'.

Authors:  S ROSENBERG; P CALABRESI
Journal:  Nature       Date:  1963-09-14       Impact factor: 49.962

5.  THE EFFECT OF DELAYED ADMINISTRATION OF FOLINIC ACID ON IMMUNOLOGICAL INHIBITION BY METHOTREXATE.

Authors:  M C BERENBAUM; I N BROWN
Journal:  Immunology       Date:  1965-03       Impact factor: 7.397

6.  Suppression of the immune response by drugs in combination.

Authors:  S BIEBER; G B ELION; G H HITCHINGS; D C HOOPER; H C NATHAN
Journal:  Proc Soc Exp Biol Med       Date:  1962-11

7.  Effects of roentgen radiation and cortisone on susceptibility of mice to Candida albicans.

Authors:  F J ROTH; J FRIEDMAN; J T SYVERTON
Journal:  J Immunol       Date:  1957-02       Impact factor: 5.422

8.  Antagonisms and antagonists.

Authors:  S LOEWE
Journal:  Pharmacol Rev       Date:  1957-06       Impact factor: 25.468

9.  The employment of combinations of drugs in the chemotherapy of neoplasia: a review.

Authors:  A GOLDIN; N MANTEL
Journal:  Cancer Res       Date:  1957-08       Impact factor: 12.701

10.  The effect of whole body x-irradiation of mice on immunity to tetanus toxoid. II. The delayed immune response to injections of tetanus toxoid.

Authors:  P H CHIN; M S SILVERMAN
Journal:  J Immunol       Date:  1956-10       Impact factor: 5.422
View more
  90 in total

1.  L-ficolin and capsular polysaccharide-specific IgG in cord serum contribute synergistically to opsonophagocytic killing of serotype III and V group B streptococci.

Authors:  Mioko Fujieda; Youko Aoyagi; Kousaku Matsubara; Yasuhito Takeuchi; Wakae Fujimaki; Misao Matsushita; John F Bohnsack; Shinji Takahashi
Journal:  Infect Immun       Date:  2012-03-26       Impact factor: 3.441

2.  The scientific assessment of combined effects of risk factors: different approaches in experimental biosciences and epidemiology.

Authors:  Wolfgang Boedeker; Thomas Backhaus
Journal:  Eur J Epidemiol       Date:  2010-05-22       Impact factor: 8.082

3.  Comparative in vitro Activity of Cefuroxime and its Interactions with Aminoglycoside Antibiotics.

Authors:  H Gaya; E M Brown; P Friedman; S E Cox
Journal:  Proc R Soc Med       Date:  1977

4.  The novel BCR-ABL and FLT3 inhibitor ponatinib is a potent inhibitor of the MDR-associated ATP-binding cassette transporter ABCG2.

Authors:  Rupashree Sen; Karthika Natarajan; Jasjeet Bhullar; Suneet Shukla; Hong-Bin Fang; Ling Cai; Zhe-Sheng Chen; Suresh V Ambudkar; Maria R Baer
Journal:  Mol Cancer Ther       Date:  2012-07-09       Impact factor: 6.261

Review 5.  Assessment of non-linear combination effect terms for drug-drug interactions.

Authors:  Gilbert Koch; Johannes Schropp; William J Jusko
Journal:  J Pharmacokinet Pharmacodyn       Date:  2016-09-16       Impact factor: 2.745

6.  Env-glycoprotein heterogeneity as a source of apparent synergy and enhanced cooperativity in inhibition of HIV-1 infection by neutralizing antibodies and entry inhibitors.

Authors:  Thomas J Ketas; Sophie Holuigue; Katie Matthews; John P Moore; Per Johan Klasse
Journal:  Virology       Date:  2011-10-22       Impact factor: 3.616

7.  Synergic action between tumor necrosis factor and endotoxins or poly(A.U) on cultured bovine endothelial cells.

Authors:  P A van de Wiel; R H Pieters; A van der Pijl; N Bloksma
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

8.  Influence of scheduling on two-drug combinations of alkylating agents in vivo.

Authors:  B A Teicher; S A Holden; S M Jones; J P Eder; T S Herman
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

9.  Analysis of antimalarial synergy between bestatin and endoprotease inhibitors using statistical response-surface modelling.

Authors:  C S Gavigan; S G Machado; J P Dalton; A Bell
Journal:  Antimicrob Agents Chemother       Date:  2001-11       Impact factor: 5.191

10.  Combined effects of multiple flavonoids on breast cancer resistance protein (ABCG2)-mediated transport.

Authors:  Shuzhong Zhang; Xinning Yang; Marilyn E Morris
Journal:  Pharm Res       Date:  2004-07       Impact factor: 4.200
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.